GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Selling and Marketing Expense

Biomics Biopharma (ASX:BBM) Selling and Marketing Expense : A$ Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Biomics Biopharma's Selling and Marketing Expense for the six months ended in . 20 was A$0.00 Mil. Biomics Biopharma does not have enough years/quarters to calculate the Selling and Marketing Expense for the trailing twelve months (TTM) ended in . 20.


Biomics Biopharma Selling and Marketing Expense Historical Data

The historical data trend for Biomics Biopharma's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Selling and Marketing Expense Chart

Biomics Biopharma Annual Data
Trend
Selling and Marketing Expense

Biomics Biopharma Semi-Annual Data
Selling and Marketing Expense

Biomics Biopharma Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.


Biomics Biopharma Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomics Biopharma (ASX:BBM) Business Description

Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines